Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,681 | -3,960 | -4,135 | -6,552 | -5,645 |
| Depreciation Amortization | N/A | N/A | N/A | 27 | 36 |
| Other Working Capital | 329 | 971 | -263 | -427 | 461 |
| Other Operating Activity | 65 | 172 | 283 | 2,305 | 410 |
| Operating Cash Flow | $-2,287 | $-2,818 | $-4,114 | $-4,647 | $-4,738 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | -500 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-500 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,005 | N/A | N/A | N/A | 11,455 |
| Financing Cash Flow | $4,005 | $N/A | $N/A | $N/A | $11,455 |
| Beginning Cash Position | 6,166 | 8,983 | 13,097 | 18,244 | 11,528 |
| End Cash Position | 7,884 | 6,166 | 8,983 | 13,097 | 18,244 |
| Net Cash Flow | $1,718 | $-2,818 | $-4,114 | $-5,147 | $6,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,287 | -2,818 | -4,114 | -4,647 | -4,738 |
| Free Cash Flow | -2,287 | -2,818 | -4,114 | -4,647 | -4,738 |